Enveric Biosciences, Inc.
ENVB
$1.23
$0.01621.34%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.57M | -9.86M | -10.59M | -15.07M | -17.29M |
| Total Depreciation and Amortization | 337.50K | 339.50K | 350.50K | 380.10K | 408.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.93M | 2.45M | 1.82M | 2.94M | 2.96M |
| Change in Net Operating Assets | -423.30K | -1.09M | -1.55M | 190.80K | -174.80K |
| Cash from Operations | -7.73M | -8.17M | -9.98M | -11.56M | -14.09M |
| Capital Expenditure | -- | 0.00 | 0.00 | 0.00 | -5.20K |
| Sale of Property, Plant, and Equipment | -- | -100.00 | -100.00 | 16.80K | 16.80K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | 0.00 | 16.90K | 11.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.05M | 5.57M | 5.05M | 4.98M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 1.05M | 1.05M | 1.05M |
| Repurchase of Preferred Stock | -- | -- | -- | -1.05M | -1.05M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.62M | 1.46M | 300.30K | 330.40K | -1.34M |
| Cash from Financing | 7.67M | 7.02M | 6.40M | 5.32M | -1.34M |
| Foreign Exchange rate Adjustments | 5.30K | -13.50K | -1.40K | 18.00K | -10.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -47.00K | -1.15M | -3.58M | -6.21M | -15.44M |